Jensen, T
Sanchiz F, Milla A, Artola N, Julia JC, Moya LM, Pedro A, et al
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
It serves as a hub molecule that connects antioxidant defense, detoxification, immune signaling, and cellular metabolism
Glutathiones ability to neutralise these ROS has led to it often being referred to as the master antioxidant
10.1016/j.cgh.2009.07.016 113 SrivastavaA.WalterN.AtkinsonP